Radioactive Iodine Therapy in Differentiated Thyroid Cancer: 2020 Update

被引：51
|
作者：
Ciarallo, Anthony [1 ]
Rivera, Juan [2 ]
机构：
[1] McGill Univ, Hlth Ctr, Dept Med Imaging, Div Nucl Med, 1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada
[2] McGill Univ, Hlth Ctr, Dept Med, Div Endocrinol & Metab, Montreal, PQ, Canada
来源：
AMERICAN JOURNAL OF ROENTGENOLOGY | 2020年 / 215卷 / 02期
关键词：
differentiated thyroid cancer; DTC; I-131; radioactive iodine therapy; RAI; thyroid cancer; RADIOIODINE-REMNANT ABLATION; I-131; METAANALYSIS; PATIENT;
D O I：
10.2214/AJR.19.22626
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OBJECTIVE. The paradigm of theranostics is based on tailoring therapy for the purpose of optimizing outcomes. This principle is being applied to radioactive iodine therapy. Consequently, thyroid cancer therapy protocols are evolving. The purpose of this article is to promote a modern approach to radioiodine therapy. CONCLUSION. This article highlights guidelines and position statements, summarizes the prognostication systems of thyroid cancer, and reviews which prescribed activities of I-131 are appropriate for each risk category.
引用
收藏
页码：285 / 291
页数：7
相关论文
共 50 条
  • [31] Radioactive iodine ablation therapy reduces the risk of recurrent disease in pediatric differentiated thyroid carcinoma
    Toraih, Eman
    Webster, Alyssa
    Pineda, Eric
    Pinion, Dylan
    Baer, Lily
    Persons, Emily
    Herrera, Marcela
    Hussein, Mohammad
    Kandil, Emad
    SURGICAL ONCOLOGY-OXFORD, 2024, 56
  • [32] Effects of apitherapy against salivary gland disorder after radioactive iodine therapy for differentiated thyroid cancer
    Kenta Nomura
    Michihiro Nakayama
    Atsutaka Okizaki
    Annals of Nuclear Medicine, 2023, 37 : 462 - 469
  • [33] Risk of primary breast cancer in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a systematic review and meta-analysis
    Carmela Nappi
    Michele Klain
    Valeria Cantoni
    Roberta Green
    Leandra Piscopo
    Fabio Volpe
    Simone Maurea
    Mario Petretta
    Alberto Cuocolo
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 1630 - 1639
  • [34] Therapy with tyrosine kinase inhibitor lenvatinib in radioactive iodine-naive advanced differentiated thyroid cancer
    Sukumar, Jasmine Singh
    Moore, William
    Khan, Saad A.
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2019, 6 (04)
  • [35] Effects of apitherapy against salivary gland disorder after radioactive iodine therapy for differentiated thyroid cancer
    Nomura, Kenta
    Nakayama, Michihiro
    Okizaki, Atsutaka
    ANNALS OF NUCLEAR MEDICINE, 2023, 37 (08) : 462 - 469
  • [36] Risk of primary breast cancer in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a systematic review and meta-analysis
    Nappi, Carmela
    Klain, Michele
    Cantoni, Valeria
    Green, Roberta
    Piscopo, Leandra
    Volpe, Fabio
    Maurea, Simone
    Petretta, Mario
    Cuocolo, Alberto
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (05) : 1630 - 1639
  • [37] Low dose radioactive iodine ablation therapy (1.11 GBq) for differentiated thyroid cancer in western Turkey
    Erkek, B. Karasah
    Gumusgoz, H. Sariyildiz
    Oral, A.
    Yazici, B.
    Akgun, A.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2024, 43 (06):
  • [38] Estimation of Second Primary Cancer Risk After Treatment with Radioactive Iodine for Differentiated Thyroid Carcinoma
    Correa, Nilton Lavatori
    de Sa, Lidia Vasconcellos
    Ramalho de Mello, Rossana Corbo
    THYROID, 2017, 27 (02) : 261 - 270
  • [39] Update on Differentiated Thyroid Cancer Staging
    Momesso, Denise P.
    Tuttle, Michael
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2014, 43 (02) : 401 - +
  • [40] Update on multikinase inhibitor therapy for differentiated thyroid cancer
    Agrawal, V. R.
    Jodon, G.
    Mushtaq, R.
    Bowles, D. W.
    DRUGS OF TODAY, 2018, 54 (09) : 535 - 545
12345